Home › Leukemia › Michigan › Detroit
Leukemia clinical trials in Detroit, MI
5 studies for Leukemia are looking for participants at sites in and around Detroit (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
RecruitingPhase 3
- Wayne State University School of Medicine, Detroit
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
RecruitingObservational study
- Wayne State University/Karmanos Cancer Institute, Detroit
- Ascension Saint John Hospital, Detroit
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
RecruitingPhase 1
- Karmanos Cancer Institute, Detroit
- Henry Ford Cancer Institute, Detroit
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
RecruitingObservational study
- Ascension Saint John Hospital, Detroit
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RecruitingPhase 1
- Karmanos Cancer Institute, Detroit
About Leukemia
Leukemia is cancer of the white blood cells. There are two types of Leukemias, acute and chronic. Learn about the differences and treatments available.
More about Leukemia on MedlinePlus
Leukemia trials in other cities
- Houston, TX31 studies
- Boston, MA27 studies
- New York City, NY21 studies
- Chicago, IL19 studies
- Los Angeles, CA17 studies
- Durham, NC14 studies
- Baldwin Park, CA14 studies
- Nashville, TN13 studies
- Columbus, OH13 studies
- Philadelphia, PA13 studies
- Atlanta, GA12 studies
- Milwaukee, WI12 studies
Other studies in Detroit
- Non-Small Cell Lung Cancer40 studies
- Breast Cancer34 studies
- Ovarian Cancer28 studies
- Cancer (all types)27 studies
- Colorectal Cancer25 studies
- Prostate Cancer23 studies
- Endometrial Cancer23 studies
- Metastatic Cancer22 studies
- Lung Cancer19 studies
- Multiple Myeloma19 studies
- Head and Neck Squamous Cell Carcinoma16 studies
- Stomach Cancer15 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.